Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Further Delays Cutback In IV Chemo Coverage

This article was originally published in PharmAsia News

Executive Summary

Australia's Health Ministry has decided to extend the Sept. 1 effective date for cutbacks in federal support for intravenous chemotherapy drugs. The delay is the third for the plan to cover only the amount used by a patient for a specific treatment rather than covering the cost of a full vial of the drug. The change was to have taken effect July 1 and then was delayed until Sept. 1, but Minister Nicola Roxon said the effective date would be sometime later, on a date yet to be selected. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel